The Future of Weight Loss DrugsPosted: May 9, 2021 in Obesity Medicine, Research, Resource by Craig Primack MD FACP
Craig Primack MD, FACP, FAAP, FOMA
The most powerful weight loss drug is currently glucagon-like peptide 1 (GLP-1).
GLP-1 is an incretin hormone that discharges from the intestine after absorbing glucose and other nutrients. It stimulates insulin secretion from the pancreas. The second primary incretin is Gastric inhibitory Polypeptide (GIP) which has insulin stimulating effects like GLP-1.
Both GLP-1 and GIP are considered gut hormones and are both involved in the control of appetite.
Semaglutide vs. Tirzepatide
In February 2020, a NEJM study was published showing that a specific GLP-1 drug with semaglutide at 2.4mg, was quite effective in weight loss. Since 2018, semaglutide (Wegovy™) has been approved for the treatment of diabetes at doses of up to 1mg. We are now waiting for its approval to treat weight loss at 2.4mg.
More recently, a study with a dual agonist with effects of both GLP-1 and GIP was released. This combo drug is called tirzepatide but has not been approved by the FDA yet.
Tirzepatide was shown to lower blood sugar levels and increase weight loss effects with 3 doses: 5, 10, and 15mg. It is considered to be slightly better than semaglutide (Ozempic®) for weight loss at its 1mg dose.
What’s to Come of Weight Loss Drugs
Obesity is a serious, chronic disease but it is treatable. Be sure to incorporate prescription drugs into your weight loss program to make it more manageable.
This is How You Lose the Weight, Once and For All
If you’re ready to say goodbye to quick fixes that never last? And you’re serious about losing weight for good? We’re the experts you can trust to guide you through a weight loss program that will not only take the weight off but keep it off. Schedule a consultation with us today.